Skip to main content

TRACT Therapeutics, Inc.

Founded: 2014

Northwestern Inventor:
Joseph Leventhal
Feinberg School of Medicine
Department of Surgery

TRACT Therapeutics, Inc. has developed a patented technology utilizing T regulatory cells (Treg) for modulation of the immune system. TRACT will commercialize this technology to become a premier global provider of an autologous (patient’s own cells) therapy that could prevent solid organ transplant rejection and eliminate or minimize the need for expensive immunosuppressive drugs. In addition to organ transplantation, TRACT will also focus its proprietary technology for the treatment of autoimmune disorders, such as rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The pipeline will sustain growth for the company.

TRACT Therapeutics, Inc. Website